Company: FTII
Filing Date: 2025-02-14
Form Type: S-4
Source: 0001493152-25-006997
Chunk: 543

Company: FutureTech II Acquisition Corp.
Filing Date: 2025-02-14
Form: S-4
Chunk 543
---
 $ 6,552,136and $ 447,229in funds due from the Sponsor during the year ended December 31, 2023, respectively.

As
of December 31, 2023 (restated) and 2022, the shares of common stock reflected on the balance sheet are reconciled in the following
table.

Schedule of Common Stock Reflected on Balance Sheet Reconciled

| Gross Proceeds                                      |     | $ | 115,000,000 |   |
| Less:                                               |     |   |             |   |
| Proceeds allocated to public warrants               |     |   |  (1,067,463 | ) |
| Temporary equity offering costs                     |     |   |  (5,635,551 | ) |
| Plus:                                               |     |   |             |   |
| Remeasurement of carrying value to redemption value |     |   |   9,003,014 |   |
| Ending Balance as of March 31, 2022                 |     |   | 117,300,000 |   |
| Remeasurement of carrying value to redemption value |     |   |   1,166,326 |   |
| Ending Balance as of December 31, 2022              |     |   | 118,466,326 |   |
| Redemption of Class A common stock                  |     |   | (64,238,888 | ) |
| Remeasurement of carrying value to redemption value |     |   |   6,552,136 |   |
| Due from Sponsor                                    |     |   |     447,229 |   |
| Ending Balance as of December 31, 2023 (restated)   |     | $ |  61,226,803 |   |

Warrant Instruments

The Company accounts for the
Public Warrants and the Private Placement Warrants issued in connection with the Initial Public Offering and the Private Placement in
accordance with the guidance contained in FASB ASC 815, “Derivatives and Hedging”. Under ASC 815-40 the Public Warrants and
the Private Placement Warrants meet the criteria for equity treatment and as such will be recorded in stockholders’ deficit. If the warrants no longer meet the criteria
for equity treatment, they will be recorded as a liability and remeasured each period with changes recorded in the statements of operations.

Net Income (Loss) Per Share

Net income (loss